紫光國微(002049.SZ)第三季度淨利潤預增95%-125%
格隆匯10月12日丨紫光國微(002049.SZ)公佈,預計2021年前三季度歸屬於上市公司股東的淨利潤13.35億元-15.40億元,同比增長95%-125%;其中,第三季度歸屬於上市公司股東的淨利潤5.51億元-6.36億元,同比增長95%-125%。
報吿期內,公司所處各細分行業下游需求旺盛,訂單飽滿,公司特種集成電路業務的產品競爭力強、客户認可度高,交付能力持續提升,營業收入和淨利潤均保持高速增長;智能安全芯片業務收入快速增長,盈利能力改善顯著。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.